Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in alzheimer’s disease

HIGHLIGHTS

  • who: Christopher Daniel Morrone from the , Canada have published the research: Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimeru2019s disease, in the Journal: (JOURNAL)
  • what: In light of these findings, the authors propose that the TgF344-AD rats are an important rodent model to investigate contributions of neuronal compensatory mechanisms to cognition across AD progression.
  • how: The authors utilized the TgF344-AD rat model as it recapitulates Au03b2 pathology hyperphosphorylation and deposition of tau into neuritic and pre-tangle inclusions and neurodegeneration including neuronal loss . The authors presented a novel . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?